Rheumatology 2000; 39: 343-346
© 2000 British Society for Rheumatology
Editorials |
Treating fibromyalgia
Department of Rheumatology and
1 Psychological Medicine, Kings College Hospital, London, UK
Fibromyalgia is a common musculoskeletal disorder, characterized by widespread pain combined with tenderness at multiple tender points. Associated features often include fatigue, unrefreshing sleep, psychological distress, irritable bowel, headaches, paraesthesia and morning stiffness. Although not universally accepted as a discrete entity [1], such patients can be readily classified by using the American College of Rheumatology (ACR) 1990 criteria [2] which require the presence of widespread pain for at least 3 months and pain on palpation of at least 11 of 18 tender points. The syndrome has replaced the label fibrositis and there is a large degree of overlap with other medically unexplained syndromes such as chronic fatigue syndrome. In all cases, a medical explanation for the pain and fatigue needs to be sought, with appropriate investigations undertaken dependent on the presentation. However, despite being the second commonest syndrome seen in some rheumatology clinics [3],
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Hazemeijer and J. J. Rasker Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting Rheumatology, April 1, 2003; 42(4): 507 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Wright, G. MacGregor, and J. K. Dawson Fibromyalgia--monotheories, monotherapies and reductionism Rheumatology, March 1, 2001; 40(3): 348 - 348. [Full Text] [PDF]
|
|